PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 13, 20262 citations

Discovery and Engineering Imine Reductase for Gram-Scale Synthesis of (S)-Nicotine.

View Full Paper
SZShifeng ZhangYZYuting ZouHWHongkui Wang

Key Points

  • The central aim is to develop an engineered imine reductase for efficient synthesis of (S)-nicotine.
  • Developed an imine reductase variant through structure-guided directed evolution.
  • Screened enzyme libraries to identify IR-55 as the parent enzyme for further modifications.
  • Performed combinatorial mutagenesis on a key loop to yield mutant M6 with enhanced enantioselectivity.
  • Regulated pH dynamically during the reaction to enhance substrate loading and conversion rates.
  • Achieved a conversion rate of 94% with a substrate loading of 250 g/L after 4 hours.
  • Developed mutant M6 demonstrated 97.7% enantioselectivity and operational efficiency.
  • Scale-up produced 1.23 g of product with 97.2% enantioselectivity and 75.9% isolated yield.

Abstract

An engineered imine reductase variant capable of synthesizing (S)-nicotine was developed through structure-guided directed evolution. Enzyme library screening identified IR-55 as an ideal parent, exhibiting high yield and good enantioselectivity. Targeted combinatorial mutagenesis of a crucial loop (residues 227-236) produced mutant M6 with 97.7% ee. By dynamically regulating the pH within the range of 7.5-8.0, a substrate loading of 250 g/L was achieved, resulting in a conversion rate of 94% after 4 h with space-time yield (STY) of 58.7 g/L/h. Scale-up with 2.5 g of substrate in 20 mL for 6 h yielded 1.23 g of product (97.2% ee, 75.9% isolated yield STY 10.3 g/L/h), demonstrating superior space-time yield and operational efficiency compared to existing biocatalytic routes. This work not only offers an efficient pathway for the industrial synthesis of (S)-nicotine through rational enzyme engineering but also provides a comprehensive strategy to overcome substrate inhibition and enzyme inactivation under high substrate concentration.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69b3ac6002a1e69014cce08fhttps://doi.org/10.1021/acs.orglett.6c00459
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficient Synthesis of (<i>S</i>)-Nornicotine using Co-Immobilized IRED and GDH in Batch and Continuous Flow Reaction Systems2024 · 5 citations
  2. 2Biotechnological potential of Paenarthrobacter nicotinovorans ATCC 49919 for the microbial conversion of nicotine and tobacco extracts into 6-hydroxynicotine2026
  3. 3Complete biosynthesis of nicotine2026 · 10 citations
  4. 4Proximity-enhanced co-immobilized enzyme cascade for efficient bioconversion of nicotine to 3-succinoylpyridine2026 · 1 citations
  5. 5Rational Design of a Flavoenzyme for Aerobic Nicotine Catabolism2024